Lancaster Urology — Lancaster, Pennsylvania

Lancaster Urology is a clinical research site located in Lancaster, Pennsylvania, United States 17604.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Lancaster Urology has participated in 15 clinical trials with 2 currently active.

Therapeutic areas: Prostate Cancer, Decision Support Systems, Clinical, Nonmetastatic Castration-Resistant Prostate Cancer.

Sponsors: Ferring Pharmaceuticals, University of California, San Francisco, MDx Health.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lancaster Urology?

Lancaster Urology has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lancaster Urology conducted?

Lancaster Urology has 15 clinical trials on record, with 2 currently active. Their work covers Prostate Cancer, Decision Support Systems, Clinical, Nonmetastatic Castration-Resistant Prostate Cancer.

Is Lancaster Urology accredited by Crixeo Health?

Yes — Lancaster Urology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Lancaster Urology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.